OK-432 therapy for lymphangioma in children: Why and how does it work?
Reference (19)
- et al.
OK-432 therapy for unresectable lymphangioma in children
J Pediatr Surg
(1991) - et al.
OK-432 therapy in 64 patients with lymphangioma
J Pediatr Surg
(1994) - et al.
A case report of sclerosing therapy with OK-432 for cystic hygroma in a child
Geka (Surgery)
(1987) - et al.
- et al.
Intracystic injection of OK-432; A new sclerosing therapy for cystic hygroma in children
Br J Surg
(1987) - et al.
Intrapleural administration of OK-432 in cancer patients: Activation of NK cells and reduction of suppressor cells
Int J Cancer
(1983) - et al.
Binding and crosslinking of 125I-labeled recombinant human TNF to cell surface receptors
J Biochem
(1986) Experimental anticancer studies. Part XXXI. On the streptococcal preparation having potent anticancer activity
Jpn J Exp Med
(1966)- et al.
Clinical studies on cell-mediated immunity in patients with malignant disease
Cancer
(1980)
There are more references available in the full text version of this article.
Cited by (0)
Presented at the 42nd Annual International Congress of the British Association of Paediatric Surgeons, Sheffield, England, July 25–28, 1995.
Copyright © 1996 Published by Elsevier Inc.